CClinicalTrials.gg
CompletedNCT05662384SBOUpdated Dec 6, 2023

Small Bowel Obstruction. A Prospective Multicener Study

An observational study in Small Bowel Obstruction, sponsored by University of Tartu. Completed at 1 site in Estonia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-06.

Sponsored by University of Tartu · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
214
Ages
18 Years and older
Sex
All
01

Study summary

To get an overview of patients hospitalized with mechanical small bowel obstruction and the evaluate the use of contrast media as part of conservative management. To analyze how many patients were operated on and in how many cases conservative measures helped.

Read the detailed description

This is a multicenter prospective study conducted at two regional hospitals of Estonia: Tartu University Hospital and North Estonian Medical Center. The data of the patients' hospitalized for SBO between May 2021 and April 2022 were collectedafter patients gave their informed consent to be enrolled in the study.

Eligible patients were adults aged 18 years or older with mechanical small bowel obstruction. Patients younger than 18 years, patients with large bowel obstruction or dynamic small bowel obstruction and/or patients who had undergone abdominal/pelvic surgery within 4 weeks of admission were excluded from the study.

Characteristics of abdominal pain (absent/intermittent/permanent), presence of nausea/vomiting, absence of flatus, results of blood tests (white blood cell count (WBC), C-reactive protein (CRP), lactate level (Lac), estimated glomerular filtration rate (eGFR)), radiology imaging techniques used, previous abdominal/pelvic surgeries, previous episodes of bowel obstruction. It was documented whether immediate surgical treatment was implemented, or whether conservative management was initiated. In the case of conservative treatment, it was recorded whether contrast media (CM) was or was not used. In the case of surgical treatment, the type of surgery (adhesiolysis/ bowel resection/ other) was recorded.

02

Conditions studied

  • Small Bowel Obstruction
03

In context

Intestinal Obstruction

160 studies on the registry are indexed under Intestinal Obstruction; 27 are open to participants now.

This study's enrollment of 214 is above the median of 152 across 68 observational studies indexed under Intestinal Obstruction.

Browse Intestinal Obstruction studies →

Lead sponsor

University of Tartu is the lead sponsor of 45 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients hospitalized with mechanical small bowel obstruction

Inclusion criteria

  • aged 18 years or older with mechanical small bowel obstruction who signed an informed consent form

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years, patients with large bowel obstruction or dynamic small bowel obstruction and/or patients who had undergone abdominal/pelvic surgery within 4 weeks of admission were excluded from the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
214 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients hospitalized with small bowel obstruction

    Patients hospitalized with a certain diagnosis during a certain period of time

    Other: No intervention is planned

Interventions

  • OtherNo intervention is planned

    Observational study, no intervention

06

What researchers measure

Primary outcomes

  1. Resolution on SBO

    Resolution of small bowel obstruction (passing gas/flatus, contrast media in the colon on the X-ray )

    Time frame: Hospitalization period (approximately 5 days)

07

Study locations

1 site
  • Tartu University Hospital
    Tartu, Tartumaa 50406, Estonia
08

References and documents

Individual participant data

Plan to share: Undecided — Patients identification numbers will be pseudonymed- the key is in a secure server and will only be accessed through smart-ID identification

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05662384
Lead sponsor
University of Tartu
Collaborators
North Estonian Medical Center
Responsible party
Liis Jaanimäe (General Surgeon, PhD student, University of Tartu) — Principal investigator
First posted
Dec 22, 2022
Start date
May 1, 2021
Primary completion
Apr 30, 2022
Completion
Oct 15, 2022
Last update
Dec 6, 2023

Study contacts

Liis Jaanimäe
principal investigator · University of Tartu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion